Online Inquiry
lenvatinib Mesylate
SPC-01221
CAS No. 857890-39-2
| Size | Price |
| 25 mg | Online Inquiry |
| Bulk Size | Online Inquiry |
VEGFR inhibitor ; FGFR inhibitor ; PDGFR inhibitor ; c-Kit inhibitor ; c-RET inhibitor
| Description |
|---|
| Lenvatinib Mesylate is a synthetic, orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor α (PDGFRα), stem cell factor receptor (KIT), and rearranged during transfection (RET). Lenvatinib Mesylate has potential antineoplastic activity. |
| Product Details | |
|---|---|
| CAS No. | CAS No. 857890-39-2 |
| Description | Lenvatinib Mesylate is a synthetic, orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor α (PDGFRα), stem cell factor receptor (KIT), and rearranged during transfection (RET). Lenvatinib Mesylate has potential antineoplastic activity. |
| Formula | C21H19ClN4O4.CH4O3S |
| Molecular Weight | 522.96 |
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
| Synonyms | N/A |
| SMILES | COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O |
| Usage | |
|---|---|
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.